↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$238KSold on the market
1Companies
Sep 8, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 202616:13 | Sep 8, 2026 | DYNDyne Therapeutics, Inc. | CEO & President, Director | S · Sell10b5-1 | $18.88 | −5,658 | 357,507 | -2% | −$107K | ||
| Aug 17, 202616:07 | Aug 13, 2026 | DYNDyne Therapeutics, Inc. | CEO & President, Director | S · Sell10b5-1 | $26.28 | −4,986 | 363,165 | -1% | −$131K |